glp 1 function Understanding GLP-1 receptor agonists and their impact on drug discovery GLP-1 Receptor Agonists in Gastrointestinal

[18,19] Impaired GLP-1 secretion and signaling is a huge problem for anyone , but particularly a diabetic

Weiss T, Carr RD, Pal S, Yang L, Sawhney B, Boggs R, et al

The phenomenon isnt unique to GLP-1 therapy

For our PsA and rheumatoid arthritis patients with obesity or diabetes, GLP-1s might reduce cardiovascular risk and possibly even blunt systemic inflammation

Originally developed for type 2 diabetes management, several of these medications have received FDA approval for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with weight-related comorbidities

Its also worth noting that, while relatively common, diarrhea is not a persistent side effect of semaglutide